Spravato is the trade name for esketamine, a refined molecular form of ketamine delivered through a nasal spray and developed specifically for adults with treatment-resistant depression (TRD) and for those with major depressive disorder (MDD) who present with active suicidal thoughts or behavior. It carries a distinction no other ketamine therapy can claim: it is the only intranasal esketamine formulation approved by the U.S. Food and Drug Administration, and it is the only ketamine-based depression treatment that most commercial and public insurance plans actively reimburse. For patients in NoMad and across Manhattan who have been priced out of self-pay ketamine alternatives, that coverage transforms what’s possible.

During a session, the patient self-administers the nasal spray while a certified clinical team monitors vitals and supervises the full treatment window. The medication acts on the brain’s glutamate system through NMDA receptor antagonism, triggering a downstream cascade that supports synaptogenesis and neuroplasticity. Conventional antidepressants such as SSRIs typically need six to eight weeks to register any therapeutic effect, and a significant portion of patients see no meaningful improvement even then. According to a peer-reviewed analysis published in The American Journal of Psychiatry, esketamine paired with a newly initiated oral antidepressant produced statistically significant improvement in depressive symptoms within 24 hours of the first dose for many participants. For people whose depression has resisted every other tool, that compressed timeline can be the difference between holding on and giving up.

At InnerMost, Spravato is not delivered as an isolated pharmaceutical event. We treat it as a clinical opening that requires therapeutic structure on either side to translate into lasting recovery, not a brief lift followed by a return to baseline.

• Spravato remains the sole FDA-approved esketamine therapy on the U.S. market, and it is reimbursed by the majority of commercial insurers, Medicare, and several Medicaid managed care plans.
• The mechanism of action through NMDA receptor modulation produces measurable symptom relief in a fraction of the time required by serotonin-based antidepressants.
• Spravato has been the subject of more rigorous regulatory scrutiny than any other ketamine therapy, including the New York State Department of Health’s controlled substance monitoring framework, which oversees how the medication is dispensed across the state.

NoMad and its surrounding Manhattan neighborhoods have a growing number of providers offering esketamine, but the experience varies dramatically between them. What patients consistently tell us makes our approach worth the choice is what happens before and after the medication itself, not just during the monitoring window. Here is what shapes our model of Spravato Treatment in NoMad, NY:

Spravato carries FDA approval for two specific adult clinical indications:

• Treatment-Resistant Depression (TRD): adults who have not achieved adequate response to at least two prior antidepressant trials in the current depressive episode
• Major Depressive Disorder (MDD) with Acute Suicidal Ideation or Behavior: adults experiencing active suicidality alongside an MDD diagnosis

A significant portion of our Spravato patients arrive having tried multiple SSRIs, SNRIs, augmentation strategies, structured psychotherapy, or several combinations of these over years, with diminishing returns each time. If that arc describes your experience, our clinicians are equipped to evaluate whether Spravato Treatment in NoMad, NY fits where you are now. Esketamine works through a fundamentally different neurochemical pathway than the medications that have failed you, which is precisely why it can succeed where they couldn’t.

Every intake includes a comprehensive medical and psychiatric review with one of our prescribers to confirm eligibility and identify which of our three Spravato pathways suits your clinical picture.

Spravato exerts therapeutic effect through several overlapping mechanisms that account for both the speed and depth of response patients report:

No two patients arrive at Spravato® on identical terms. Some are managing high-intensity symptoms and need supervised access to the medication as quickly as their insurance authorization allows. Others are entering treatment with stable psychotherapeutic support already in place and want to add the medication to deepen that work. Our three Spravato formats are designed to accommodate the full range. The right fit will be identified during your initial consultation.

Care at our practice begins well before the first dose and continues well after, with a clear sequence designed to make each phase intelligible. Each session takes place in a private treatment suite at our Manhattan center, and our clinical team remains accessible throughout the arc of treatment.

Physical environment is part of how Spravato lands. Our Manhattan center was designed from the ground up to support the patient experience rather than to imitate a procedural medical office. Every surface, sound profile, and lighting choice was considered through the lens of how the nervous system actually responds during deep inner work.

Even within an FDA-approved clinical framework, set and setting influence outcomes. Set refers to the mindset you bring into a session; setting refers to the room around you. We’ve built around both. From the recovery suites where you rest after dosing to the materials that line each treatment room, the space exists to reduce friction and support the therapeutic process.

Our clinic is located at 137 East 25th Street, 11th Floor, in the Gramercy neighborhood of Manhattan, a short walk from the heart of NoMad and easily reached from Flatiron, Murray Hill, Midtown South, and the broader Madison Square area.

Financial barriers shouldn’t determine who has access to evidence-based mental health care. Here’s how cost works at our practice for Spravato treatment clinic in NoMad, NY services:

If you live or work in NoMad and want to find out whether Spravato is the right next step, we’d welcome the conversation. Book a complimentary discovery call with one of our care coordinators to talk through your situation, ask questions, and gauge whether our approach feels like a fit. There’s no obligation, no pressure, just an honest exchange about your options. Our clinic at 137 East 25th Street, 11th Floor is a short walk from the heart of the neighborhood, and we’d be glad to help you decide whether it’s the right next move.